| T-Cell and NK-Cell Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 150show all (up to 200) |
|---|
| → investigated in trials for | Cyclophosphamidesmall molecule 103 trials (31 active) · roll-up of the cancer and its descendants | — | — | T-Cell and NK-Cell Neoplasm | 103 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 59 trials (11 active) · roll-up of the cancer and its descendants | — | — | T-Cell and NK-Cell Neoplasm | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 58 trials (13 active) · roll-up of the cancer and its descendants | — | — | T-Cell and NK-Cell Neoplasm | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 55 trials (18 active) · roll-up of the cancer and its descendants | — | — | T-Cell and NK-Cell Neoplasm | 55 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 49 trials (16 active) · roll-up of the cancer and its descendants | — | — | T-Cell and NK-Cell Neoplasm | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 48 trials (15 active) · roll-up of the cancer and its descendants | — | — | T-Cell and NK-Cell Neoplasm | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 44 trials (15 active) · roll-up of the cancer and its descendants | — | — | T-Cell and NK-Cell Neoplasm | 44 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 43 trials (10 active) · roll-up of the cancer and its descendants | — | — | T-Cell and NK-Cell Neoplasm | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 40 trials (10 active) · roll-up of the cancer and its descendants | — | — | T-Cell and NK-Cell Neoplasm | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 40 trials (11 active) · roll-up of the cancer and its descendants | — | — | T-Cell and NK-Cell Neoplasm | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 35 trials (7 active) · roll-up of the cancer and its descendants | — | — | T-Cell and NK-Cell Neoplasm | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 33 trials (3 active) · roll-up of the cancer and its descendants | — | — | T-Cell and NK-Cell Neoplasm | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegaspargaseother 31 trials (8 active) · roll-up of the cancer and its descendants | — | — | T-Cell and NK-Cell Neoplasm | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 30 trials (2 active) · roll-up of the cancer and its descendants | — | — | T-Cell and NK-Cell Neoplasm | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 27 trials (4 active) · roll-up of the cancer and its descendants | — | — | T-Cell and NK-Cell Neoplasm | 27 | Observed | clinicaltrials | graph → |